G protein-coupled receptor 37-like 1 modulates astrocyte glutamate transporters and neuronal NMDA receptors and is neuroprotective in ischemia.
Sarah JollyNarges BazarganiAlejandra C QuirogaNigel P PringleDavid AttwellWilliam D RichardsonHuiliang LiPublished in: Glia (2017)
We show that the G protein-coupled receptor GPR37-like 1 (GPR37L1) is expressed in most astrocytes and some oligodendrocyte precursors in the mouse central nervous system. This contrasts with GPR37, which is mainly in mature oligodendrocytes. Comparison of wild type and Gpr37l1-/- mice showed that loss of GPR37L1 did not affect the input resistance or resting potential of astrocytes or neurons in the hippocampus. However, GPR37L1-mediated signalling inhibited astrocyte glutamate transporters and - surprisingly, given its lack of expression in neurons - reduced neuronal NMDA receptor (NMDAR) activity during prolonged activation of the receptors as occurs in ischemia. This effect on NMDAR signalling was not mediated by a change in the release of D-serine or TNF-α, two astrocyte-derived agents known to modulate NMDAR function. After middle cerebral artery occlusion, Gpr37l1 expression was increased around the lesion. Neuronal death was increased by ∼40% in Gpr37l1-/- brain compared to wild type in an in vitro model of ischemia. Thus, GPR37L1 protects neurons during ischemia, presumably by modulating extracellular glutamate concentration and NMDAR activation.
Keyphrases
- fatty acid
- wild type
- cerebral ischemia
- middle cerebral artery
- poor prognosis
- rheumatoid arthritis
- multiple sclerosis
- blood pressure
- type diabetes
- spinal cord injury
- white matter
- binding protein
- long non coding rna
- blood brain barrier
- internal carotid artery
- subarachnoid hemorrhage
- skeletal muscle
- heart rate variability
- high fat diet induced